发明名称 TREATMENT METHOD USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATE
摘要 <p><P>PROBLEM TO BE SOLVED: To provide a treatment method of cancer in a mammal that is characterized by overexpression of an ErbB receptor, and does not respond or poorly responds to treatment using an anti-ErbB antibody. <P>SOLUTION: A therapeutically effective amount of a conjugate of an anti-ErbB receptor antibody and a maytansinoid is administered to the mammal. Further, a product suitable for using this method is provided. Concretely, the method is effective for cancer treatment targeting the ErbB receptor, using an anti-ErbB receptor antibody-maytansinoid conjugate. <P>COPYRIGHT: (C)2011,JPO&INPIT</p>
申请公布号 JP2011105755(A) 申请公布日期 2011.06.02
申请号 JP20110020019 申请日期 2011.02.01
申请人 GENENTECH INC;IMMUNOGEN INC 发明人 ERICKSON SHARON;SCHWALL RALPH;SLIWKOWSKI MARK X;BLATTLER WALTER
分类号 A61K39/395;A01K67/027;A61K31/537;A61K47/48;A61P1/00;A61P5/00;A61P11/00;A61P13/08;A61P13/10;A61P13/12;A61P15/00;A61P35/00;C07K16/28;C12N15/85 主分类号 A61K39/395
代理机构 代理人
主权项
地址